Advanced Biomed (ADVB) Operating Expenses (2023 - 2026)

Advanced Biomed has disclosed Operating Expenses across 4 years of filings, most recently posting $519836.0 for Q1 2026.

• Operating Expenses for Q1 2026 came in at $519836.0, down 8.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.4 million (up 63.41% YoY), and the FY2025 annual result was $3.0 million, up 18.86% from the prior year.
• Operating Expenses came in at $519836.0 for Q1 2026 at Advanced Biomed, up from $396642.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.9 million in Q2 2025 to a low of $280064.0 in Q4 2024.
• The 4-year median for Operating Expenses is $545710.5 (2025), against an average of $685520.4.
• Across the five-year window, Operating Expenses plunged 57.0% in 2024 and soared 176.16% in 2025, its largest moves.
• Advanced Biomed's Operating Expenses stood at $651302.0 in 2023, then slumped by 57.0% to $280064.0 in 2024, then surged by 41.63% to $396642.0 in 2025, then jumped by 31.06% to $519836.0 in 2026.
• The last three Operating Expenses figures came in at $519836.0 (Q1 2026), $396642.0 (Q4 2025), and $523914.0 (Q3 2025), per Business Quant data.